Nanosonics
About the author:
- Author name:
- By Scott Power
- Job title:
- Senior Analyst
- Date posted:
- 30 September 2014, 3:42 PM
- Sectors Covered:
- Healthcare, Life Sciences
Nanosonics (NAN) CEO Michael Kavanagh presented to our network on Thursday 25 September. NAN is a leader in infection control solutions. With Hospital Acquired Infection (HIA) a hot topic for the medical community and the regulators Nanosonics is in a sweet spot.
You can watch part of the network presentation below:
More information
If you are interested in finding out more, please contact your nearest Morgans office.
Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.
-
Print this page
-
Copy Link